These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9117779)

  • 21. Reteplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Wooster MB; Luzier AB
    Ann Pharmacother; 1999 Mar; 33(3):318-24. PubMed ID: 10200858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute myocardial infarction: thrombolytic therapy in ambulance?].
    Martens F
    Internist (Berl); 2001 May; 42(5):682-5. PubMed ID: 11400575
    [No Abstract]   [Full Text] [Related]  

  • 23. Third generation plasminogen activators in the treatment of acute myocardial infarction.
    Talley JD
    J Ark Med Soc; 1996 Apr; 92(11):587-8. PubMed ID: 8675487
    [No Abstract]   [Full Text] [Related]  

  • 24. Reteplase but not alteplase affects early soluble PECAM-1 and P-selectin release in patients with acute myocardial infarction.
    Gurbel PA; Dalesandro MR; Serebruany VL
    Thromb Haemost; 1998 Oct; 80(4):725. PubMed ID: 9799011
    [No Abstract]   [Full Text] [Related]  

  • 25. Frequency of "optimal anticoagulation" for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023). ALKK Study Group.
    Zeymer U; von Essen R; Tebbe U; Niederer W; Mäurer W; Vogt A; Neuhaus KL
    Am J Cardiol; 1995 Nov; 76(14):997-1001. PubMed ID: 7484879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bolus fibrinolytic therapy in acute myocardial infarction].
    Pinelli G; Urbinati S
    Ital Heart J Suppl; 2001 Dec; 2(12):1360-2. PubMed ID: 11838360
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of reteplase with alteplase for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
    N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-dose thrombolytic following myocardial infarction.
    Furniss SS; Millar RN; Commerford PJ
    S Afr Med J; 1997 Feb; 87(2):179, 182. PubMed ID: 9107231
    [No Abstract]   [Full Text] [Related]  

  • 29. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolysis (Consensus about post-myocardial infarction treatment)].
    Arq Bras Cardiol; 1995 Mar; 64(3):271-80. PubMed ID: 7487519
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 32. Newer thrombolytic drugs for acute myocardial infarction.
    Reddy DS
    Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolytic treatment in acute myocardial infarction.
    Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
    Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful thrombolysis for acute myocardial infarction in Type I von Willebrand's disease (vWD).
    Fragasso G; Camba L; Pizzetti G; Pagnotta P; Chierchia SL
    Am J Hematol; 1998 Feb; 57(2):180. PubMed ID: 9462554
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolytic therapy for myocardial infarction.
    Brophy J
    N Engl J Med; 1998 Feb; 338(8):545-6; author reply 546-7. PubMed ID: 9471557
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombolytic therapy].
    Matsuda T
    Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolytic therapy for myocardial infarction.
    Frei S
    N Engl J Med; 1998 Feb; 338(8):545; author reply 546-7. PubMed ID: 9471556
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current clinical use of reteplase for thrombolysis. A pharmacokinetic-pharmacodynamic perspective.
    Martin U; Kaufmann B; Neugebauer G
    Clin Pharmacokinet; 1999 Apr; 36(4):265-76. PubMed ID: 10320949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trial results with a new plasminogen activator.
    Bode C; Peter K; Moser M; Smalling RW; Weaver WD
    Eur Heart J; 1997 Dec; 18 Suppl F():F17-21. PubMed ID: 9447336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.